Calado, Jerlita R.

HRN: 00-95-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/22/2025
08/05/2025
IV
600mg
Q6H
Infected Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: